Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2003-09-13
Target enrollment:
Participant gender:
Summary
Current therapies for Low-grade Non-Hodgkin's Lymphoma provide limited benefit to the
patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove
beneficial in the treatment of Low-grade Non-Hodgkin's Lymphoma.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Low-grade Non-Hodgkin's Lymphoma.